Skip to main content
Log in

Occupational asthma follow-up — which markers are elevated in exhaled breath condensate and plasma?

  • Original Paper
  • Published:
International Journal of Occupational Medicine and Environmental Health

Abstract

Objectives

To search for optimal markers in the exhaled breath condensate (EBC), plasma and urine that would reflect the activity/severity of occupational asthma (OA) after the withdrawal from the exposure to the allergen.

Material and Methods

Markers of oxidative stress: 8-iso-prostaglandin {ie206-1} (8-isoprostane, 8-ISO), malondialdehyde (MDA), 4-hydroxy-trans-2-nonenale (HNE), cysteinyl leukotrienes (LT) and LTB4 were determined using liquid chromatography and mass spectrometry in 43 subjects with immunological OA (49.3±11.8 years), removed from the exposure to the sensitizing agent 10.5±6.5 years ago; and in 20 healthy subjects (49.0±14.9 years). EBC was harvested both before and after the methacholine challenge test. In parallel, identical markers were collected in plasma and urine. The results were analyzed together with forced expiratory volume in one second (FEV1), blood eosinophils, immunoglobulin E (IgE) and eosinophilic cationic protein (ECP) and statistically evaluated (Spearman rank correlation rS, two- or one-sample t tests and alternatively Kruskal Wallis or pair Wilcoxon tests).

Results

Several parameters of lung functions were lower in the patients (FEV1% predicted, MEF25% and MEF50%, Rtot%, p < 0.001). Shorter time interval since the removal from the allergen exposure correlated with higher ECP (rS = 0.375) and lower FEV1%, MEF25% and MEF50% after methacholine challenge (rS = −0.404, −0.425 and −0.532, respectively). In the patients, IgE (p < 0.001) and ECP (p = 0.009) was increased compared to controls. In EBC, 8-ISO and cysteinyl LTs were elevated in the asthmatics initially and after the challenge. Initial 8-ISO in plasma correlated negatively with FEV1 (rS = −0.409) and with methacholine PD20 (rS = −0.474). 8-ISO in plasma after the challenge correlated with IgE (rS = 0.396).

Conclusions

The improvement in OA is very slow and objective impairments persist years after removal from the exposure. Cysteinyl LTs and 8-ISO in EBC and 8-ISO in plasma might enrich the spectrum of useful objective tests for the follow-up of OA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fenclová Z, Urban P, Pelclová D, Voriskova M, Havlová D. [Occupational diseases reported in the Czech Republic in 2012]. Prakt Lék. 2013;93(3):93–99. Czech.

    Google Scholar 

  2. Klusáčková P, Lebedová J, Pelclová D, Šalandová J, Šenholdová Z, Navrátil T. Occupational asthma and rhinitis in workers from a lasamide production line. Scand J Work Environ Health. 2007;33(1):74–78.

    Article  PubMed  Google Scholar 

  3. Talini D, Novelli F, Melosini L, Bacci E, Bartoli ML, Cianchetti S, et al. May the reduction of exposure to specific sensitizers be an alternative to work cessation in occupational asthma? Results from a follow-up study. Int Arch Allergy Immunol. 2012;157(2):186–193, http://dx.doi.org/10.1159/000327550.

    Article  CAS  PubMed  Google Scholar 

  4. Klusáčková P, Pelclová D, Lebedová J, Marečková H, Brabec M. Occupational asthma after withdrawal from the occupational allergen exposure. Ind Health. 2006;44(4):629–638, http://dx.doi.org/10.2486/indhealth.44.629.

    Article  PubMed  Google Scholar 

  5. Krakowiak A, Walusiak J, Krawczyk P, Wiszniewska M, Dudek W, Wittczak T, et al. IL-18 levels in nasal lavage after inhalatory challenge test with flour in bakers diagnosed with occupational asthma. Int J Occup Med Environ Health. 2008;21(2):165–172, http://dx.doi.org/10.2478/v10001-008-0015-y.

    Article  PubMed  Google Scholar 

  6. Świerczyńska-Machura D, Krakowiak A, Wiszniewska M, Dudek W, Walusiak J, Pałczyński C. Exhaled nitric oxide levels after specific inahalatory challenge test in subjects with diagnosed occupational asthma. Int J Occup Med Environ Health. 2008;21(3):219–225, http://dx.doi.org/10.2478/v10001-008-0024-x.

    PubMed  Google Scholar 

  7. Čáp P, Chládek J, Pehal F, Malý M, Petrů V, Barnes PJ, et al. Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients. Thorax. 2004;59(6):465–470, http://dx.doi.org/10.1136/thx.2003.011866.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Al-Samri MT, Benedetti A, Préfontaine D, Olivenstein R, Lemière C, Nair P, et al. Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: A prospective study using multiple samples. J Allergy Clin Immunol. 2010;125(5):1161–1163, http://dx.doi.org/10.1016/j.jaci.2010.02.005.

    Article  CAS  PubMed  Google Scholar 

  9. Lemiere C, Chaboillez S, Welman M, Maghni K. Outcome of occupational asthma after removal from exposure: A follow-up study. Can Respir J. 2010:17(2):61–66.

    PubMed Central  PubMed  Google Scholar 

  10. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001;163(7):1693–1722.

    Article  CAS  PubMed  Google Scholar 

  11. Horvath I, Hunt J, Barnes PJ. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Res J. 2005;26(3):523–548, http://dx.doi.org/10.1183/09031936.05.00029705.

    Article  CAS  Google Scholar 

  12. Antczak A, Górski P. Markers of pulmonary diseases in exhaled breath condensate. Int J Occup Med Environ Health. 2002;15(4):317–323.

    PubMed  Google Scholar 

  13. Holgate ST, Peter-Golden M, Panettieri RA, Henderson WR. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol. 2003;111(Suppl):S18–S36.

    Article  CAS  PubMed  Google Scholar 

  14. Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J. 2003;21(4):589–593, http://dx.doi.org/10.1183/09031936.03.00022203.

    Article  CAS  PubMed  Google Scholar 

  15. Montuschi P. Exhaled breath condensate: 8-isoprostane and eicosanoids. In: Horvath I, de Jongste JC, editors. Exhaled Biomarkers. Eur Respir Soc Monogr. 2010;49:196–206, http://dx.doi.org/10.1183/1025448x.00011210.

    Article  Google Scholar 

  16. Baraldi E, Ghiro L, Piovan V, Carraro S, Ciabattoni G, Barnes PJ, et al. Increased exhaled 8-isoprostane in childhood asthma. Chest. 2003;124(1):25–31, http://dx.doi.org/10.1378/chest.124.1.25.

    Article  CAS  PubMed  Google Scholar 

  17. Klusáčková P, Lebedová J, Kačer P, Kuzma M, Brabec M, Pelclová D, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate in bronchoprovocation tests with occupational allergens. Prostaglandins Leukot Essent Fatty Acids. 2008;78(4–5):281–292, http://dx.doi.org/10.1016/j.plefa.2008.03.006.

    Article  PubMed  Google Scholar 

  18. Battaglia S, den Hertog H, Timmers MC, Lazeroms SPG, Vignola AM, Rabe KF, et al. Small airways function and molecular markers in exhaled air in mild asthma. Thorax. 2005;60(8):639–644, http://dx.doi.org/10.1136/thx.2004.035279.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Bousquet J, Heinzerling L, Bachert C, Papadopoulos NG, Bousquet PJ, Burney PG, et al. Global Allergy and Asthma European Network; Allergic Rhinitis and its Impact on Asthma. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67(1):18–24, http://dx.doi.org/10.1111/j.1398-9995.2011.02728.x.

    Article  CAS  PubMed  Google Scholar 

  20. Le Moual N, Siroux V, Pin I, Kauffmann F, Kennedy SM. Epidemiological study on the genetics and environment of asthma. Asthma severity and exposure to occupational asthmogens. Am J Respir Crit Care Med. 2005;172(4):440–445.

    Article  PubMed  Google Scholar 

  21. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report working party. Standardization of Lung Function Tests. European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J. 1993;6(Suppl 16):5–40.

    Article  PubMed  Google Scholar 

  22. Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to histamine: A method and clinical survey. Clin Allergy. 1977;7(3):235–243, http://dx.doi.org/10.1111/j.1365-2222.1977.b01448.x.

    Article  CAS  PubMed  Google Scholar 

  23. Sterk PJ, Fabbri LM, Quanjer PhH, Cockcroft DW, O’Byrne PM, Anderson SD, et al. Airway Responsiveness. Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Report Working Party. Standardization of Lung Function Tests. European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J. 1993;6(Suppl 16):53–83.

    Article  PubMed  Google Scholar 

  24. APS Instruction manual 1986, version 2, Art. No. 780092, Erich Jaeger GmbH&Co Höchberg.

  25. Syslová K, Kačer P, Kuzma M, Pankrácová A, Fenclová Z, Vlčková S, et al. LC-ESI-MS/MS method for oxidative stress multimarker screening in the exhaled breath condensate of asbestosis/silicosis patients. J Breath Res. 2010;4(1):017104, http://dx.doi.org/10.1088/1752-7155/4/1/017104.

    Article  PubMed  Google Scholar 

  26. Syslová K, Kačer P, Vilhanová B, Kuzma M, Lipovová P, Fenclová Z, et al. Determination of cysteinyl leukotrienes in exhaled breath condensate: method combining immunoseparation with LC-ESI-MS/MS. J Chromatogr B. 2011;879(23):2220–2228, http://dx.doi.org/10.1016/j.jchromb.2011.06.004.

    Article  Google Scholar 

  27. Syslová K, Kačer P, Kuzma M, Lebedová J, Klusáčková P, Fenclová Z, et al. Determination of 8-iso-prostaglandin F2a in exhaled breath condensate by method combining immunoseparation with LC-ESI-MS. J Chromatogr B. 2008;867(1):8–14, http://dx.doi.org/10.1016/j.jchromb.2008.02.019.

    Article  Google Scholar 

  28. Syslová K, Kačer P, Kuzma M, Najmanová V, Fenclová Z, Vlčková S, et al. Rapid and easy method for monitoring oxidative stress markers in body fluids of patients with asbestos or silica-induced lung diseases. J Chromatogr B. 2009;877(24):2477–2486, http://dx.doi.org/10.1016/j.jchromb.2009.06.008.

    Article  Google Scholar 

  29. Ono E, Mita H, Taniguchi M, Higashi N, Tsuburai T, Hasegawa M, et al. Increase in inflammatory mediator concentrations in exhaled breath condensate after allergen inhalation. J Allergy Clin Immunol. 2008;122(4):768–773, http://dx.doi.org/10.1016/j.jaci.2008.06.009.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniela Pelclová.

Additional information

Study support was provided by the Research Project of the Charles University in Prague P28/LF/6 and EU Project “Material-technical Research Base for the Diagnostics and Treatment of Environmentally-caused and Oncological Disorders and their Risks, in the General University Hospital in Prague” (reg. No. CZ.2.16/3.1.00/24012) from OP Prague Competitiveness. Manager of project: Jan Malík, Professor, MD, PhD.

About this article

Cite this article

Pelclová, D., Fenclová, Z., Vlčková, Š. et al. Occupational asthma follow-up — which markers are elevated in exhaled breath condensate and plasma?. IJOMEH 27, 206–215 (2014). https://doi.org/10.2478/s13382-014-0243-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2478/s13382-014-0243-2

Key words

Navigation